Faus & Moliner continues to lead the pharmaceutical law in Spain

Chambers and Partners has published the 2021 edition of the Chambers Europe Guide, in which, based on opinions of clients and other lawyers, the leading lawyers and law firms in Europe are identified and classified and Faus & Moliner appears once again as the leading law firm in pharmaceutical law in Spain.

Those consulted by the Chambers & Partners team remark as the main strength of the firm its leadership in regulatory matters on the life sciences industry as well as on pricing and reimbursement. Likewise, they highlight its wide experience on promotional material issues and affirm that the team “is pragmatic and clear in their advice” and  that “is a pleasure to work with them”.

Information published by Chambers & Partners on its webpage:

What the team is known for Prestigious Barcelona-based boutique with a stand-out reputation in regulatory issues relating to the life sciences market. Regularly retained by key players from the pharmaceutical and medical devices industries to advise on a range of matters, spanning licence agreements and compliance projects. Also offers strength in pricing and reimbursement matters. Showcases prowess in issues relating to promotional material.

Strengths One client reports that the team is “pragmatic and clear in their advice as well as responsive and reactive to the client’s needs.”

“The service and quality of advice are excellent,” enthuses another client, who adds that “it is a real pleasure to work with them.”

Work highlights Advised Novartis and Pfizer on the Spanish Transparency Council’s ruling pertaining to the publication of confidential information on the price of various products.

Notable practitioners:

Jordi Faus offers expert advice on regulatory issues, medicinal product pricing and competition matters. Clients state: “He has outstanding experience and impressive knowledge of life sciences legal issues. He is a quick thinker, able to adapt to any situation.”

Xavier Moliner is regularly instructed by pharmaceuticals and medical device companies. He deftly handles complex regulatory issues and litigation relating to public procurements. “He is amazing at providing me with quick counselling,” a client remarks.